Crossref
Additively Manufactured Plasmonic Platforms for Light-Triggered and Programmable Drug Release
Pharmaceutical Sciences and Drug Design · 2026 · 6 (2) · 166-188
DOI: 10.51847/klvdltg1q5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2026. Verfasst von Claire Dupont und 1 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dupont, C., & Martin, J. (2026). Additively Manufactured Plasmonic Platforms for Light-Triggered and Programmable Drug Release. Pharmaceutical Sciences and Drug Design, 6(2), 166-188. https://doi.org/10.51847/klvdltg1q5
Vancouver
Dupont C, Martin J. Additively Manufactured Plasmonic Platforms for Light-Triggered and Programmable Drug Release. Pharmaceutical Sciences and Drug Design. 2026;6(2):166-188. doi:10.51847/klvdltg1q5
BibTeX
@article{Dupont2026,
author = {Dupont, Claire and Martin, Julien},
title = {Additively Manufactured Plasmonic Platforms for Light-Triggered and Programmable Drug Release},
journal = {Pharmaceutical Sciences and Drug Design},
year = {2026},
volume = {6},
number = {2},
pages = {166--188},
doi = {10.51847/klvdltg1q5}
}
EUVIMED